Purpose To clarify pre-and postoperative C-reactive protein (CRP) levels in patients with facial fractures and to investigate the influence of perioperatively administered dexamethasone on postoperative CRP levels. Patients and methods Facial fracture patients were randomized to receive perioperatively a total dose of 30 mg of dexamethasone (Oradexon®), whereas patients in the control group received no glucocorticoid. The analysis included patients who had CRP measured pre-and postoperatively. Results A total of 73 adult patients with facial fractures were included in the final analysis. Mean CRP level was elevated preoperatively and the level increased further after surgery. However, postoperative CRP rise was significantly impeded by dexamethasone (p < 0.001), regardless of gender, age, treatment delay, site of fracture, surgical approach, and duration of surgery. CRP rise halved on the 1st postoperative day when dexamethasone was used. In addition, dexamethasone resulted in a CRP decrease on the 2nd postoperative day, whereas the CRP rise continued in the control group. Conclusions CRP rise is a normal body response after facial fracture and surgery that can be markedly reduced with dexamethasone. CRP changes should be considered with caution if perioperative dexamethasone is used.
Introduction
C-reactive protein (CRP) increases with inflammation and tissue damage [1] . CRP is primarily synthesized in the liver and produced in response to various stimuli mediators of the body, the most important of which are the inflammatory cytokines interleukin-6 (IL-6) and interleukin-1β (IL-1β) [2] [3] [4] . Therefore, CRP is applicable for measuring the body's response to inflammatory and infectious ailments.
Short-term glucocorticoids are beneficial for preventing nausea after general anesthesia [5] . In facial surgery, they prevent postoperative oedema [6] and diminish postoperative pain [6] [7] [8] . Glucocorticoids blunt the inflammatory and immune response of the body, affecting cytokine activity in various ways [9, 10] . As a negative consequence, however, surgical wound healing may be retarded, and the risk for surgical site infection may increase [11] [12] [13] . The postoperative increase in CRP may be attenuated by glucocorticoids [14, 15] . How and to what extent perioperatively administered glucocorticoids affect postoperative CRP levels after surgery of facial fractures in particular remain unknown.
The aims of the study were to clarify (1) pre-and postoperative CRP levels in patients diagnosed with and undergoing surgical intervention of facial fracture and (2) how and to what extent perioperatively administered highdose, short-term dexamethasone influences postoperative CRP levels.
Patients and methods

Study design
The patients in this study were drawn from a larger cohort of healthy adult dentate patients who had been recruited for a clinical follow-up study in order to clarify the benefits and drawbacks of perioperative dexamethasone in association with surgery of facial fracture. Included in the follow-up study were patients with three types of simple fractures: (1) mandibular fractures (i.e., one or two fractures in dentate areas that had been treated with open reduction and fixed with titanium miniplates in one or two intraoral approaches), (2) zygomatic complex fractures (i.e., unilateral fractures that had been treated with open or closed reduction with or without fixation with titanium miniplates via an intra-and/or extraoral approach), and (3) orbital wall fractures (i.e., fractures that had been reconstructed with titanium mesh or a bone transplant from the iliac crest).
For each fracture type, the patients were randomly assigned either to serve as a control, receiving no glucocorticoids, or to receive dexamethasone (Oradexon®) to a total dose of 30 mg. Randomization was implemented by sealed envelopes. The patients in the study group were given dexamethasone 10 mg intravenously during induction of anesthesia and an additional 10 mg intramuscularly every 8 h for 16 h, for a total dose of 30 mg. All patients were given antibiotics until the 7th to 10th postoperative day, starting with three doses of cefuroxime 1.5 g intravenously in the ward during the first 24 h postoperatively and followed by three doses of cephalexin 500 mg orally per day. Patients with allergies were given four doses of clindamycin per day by corresponding routes. No surgical drains were used.
Inclusion and exclusion criteria for the analysis
Of 130 potential patients fulfilling the inclusion criteria, 122 agreed to participate in the follow-up study. Of these, 49 were excluded from the analysis because of missing preoperative or first postoperative day CRP values, failure to receive all scheduled dexamethasone doses, or postoperative surgical site infection. Thus, a total of 73 patients were included in this study.
Evaluation of CRP levels
Measurements of CRP levels were not included in the initial study protocol. For the present analysis, CRP values were identified retrospectively from the patient files.
CRP was measured using an immunoturbometric assay (Roche Tina-Quant C-Reactive Protein CRPL3 Gen. 3; Roche, Basel, Switzerland) and expressed as mg/L. The normal value is < 3 mg/L. From the laboratory reports, preoperative CRP levels as well as the levels on the 1st and 2nd postoperative days were recorded. All preoperative CRP measurements were performed 0-1 day before surgery and before dexamethasone administration.
Study variables
The outcome variable was CRP. The primary predictor variable was the perioperative use of dexamethasone. Other explanatory variables included in the analysis were age, gender, treatment delay, fracture type, surgical approach, and duration of surgery.
Data analysis
For data analysis, age of the patients was classified as (1) < 37 years or (2) ≥ 37 years. Treatment delay was classified as (1) < 2 days, (2) ≥ 2 but < 5 days, and (3) ≥ 5 days. Surgical approach was classified as (1) extraoral (including patients who underwent exclusively extraoral approach) and (2) intraoral (including patients who underwent exclusively intraoral or combined intra-and extraoral approach). Duration of surgery was classified as (1) < 45 min or (2) ≥ 45 min.
Significant differences of gender, fracture site, and surgical approach with perioperative use of dexamethasone were evaluated by Chi-square tests. Differences in means of age, duration of surgery, preoperative level of CRP, and change of CRP from preoperative level to 1st and 2nd postoperative day according to perioperative use of dexamethasone were analyzed with Wilcoxon two-sample test. Differences in means of CRP from preoperative level to 1st and 2nd postoperative day according to perioperative use of dexamethasone were also analyzed as stratified by gender, age group, treatment delay, fracture site, surgical approach, and duration of surgery. Table 1 shows demographic and clinical data of the 73 patients. Dexamethasone was administered to 37 (51%) of the 73 patients. All 73 patients had CRP values measured preoperatively and on the 1st postoperative day. Sixty-five patients had an additional CRP value measured on the 2nd postoperative day. When patients who received dexamethasone were compared with those who did not receive it, no significant differences were observed in male/female ratio, average age, average treatment delay, fracture site (mandibular, zygomatic complex, or orbital fractures), surgical approach, average duration of surgery, and average level of CRP preoperatively.
Results
The mean preoperative CRP level in 73 patients was elevated to 11.2 mg/L (Table 1) . Mean CRP value increased further after surgery in both the dexamethasone group and controls. However, dexamethasone impeded postoperative CRP rise significantly ( Table 2 ). The mean CRP value increased by 28.3 units in the controls, but by only 5.1 units in the dexamethasone group during the first postoperative day (p < 0.001). On the second postoperative day, the mean CRP value increased further in the controls, whereas it decreased in the dexamethasone group (p < 0.001). Table 3 summarizes the changes in mean CRP levels according to use of dexamethasone stratified by explanatory variables (gender, age group, treatment delay, site of fracture, surgical approach, or duration of surgery). Dexamethasone impeded postoperative CRP rise, the findings being statistically significant in each strata, except on the first postoperative day in females and in patients whose treatment delay was < 2 days.
Discussion
The aims of this study were to clarify (1) pre-and postoperative CRP levels in patients diagnosed with and undergoing surgical intervention of facial fracture and (2) how and to what extent perioperatively administered highdose, short-term dexamethasone influences postoperative CRP levels. Our results revealed an elevated mean CRP level of 11.2 mg/L preoperatively. The level increased further after surgery in both the dexamethasone group and controls. However, postoperative CRP rise was significantly impeded by dexamethasone, regardless of gender, age, treatment delay, site of fracture, surgical approach, and duration of surgery.
Regarding the relationship between CRP level and facial trauma, our results are in line with those of Iizuka et al. [16] . The authors had shown an association between mandibular fracture and increase in CRP value preoperatively. Further, they had observed that after surgery there was always an increase in CRP level, which reached its maximum on the second postoperative day. Parallel results were reported by Kiran and Desai, who observed a marked increase in CRP levels during the first postoperative 24 h in patients treated for mandibular fractures, the levels normalizing about 1 week after surgery [17] .
Previous papers have demonstrated the benefits of systemic dexamethasone in association with recovery from surgery in general [14] and from facial surgery in particular [8, 18] . Dexamethasone is also preferred as an antiemetic drug [19] ; however, our recent study showed no benefit in routine use in facial trauma patients [20] . As dexamethasone impedes inflammatory response in general and CRP rise in particular, diagnosis and treatment of postoperative surgical site infection may be delayed. This is important to acknowledge since dexamethasone itself may predispose to infection, which we have shown in previous facial fracture studies [11] [12] [13] . The same phenomenon was also shown by Abdelmalak et al. who observed a higher rate of infections in vascular surgery patients with perioperatively administered dexamethasone, despite significantly decreased CRP levels [15] . We consider the use of dexamethasone in association with surgical treatment of facial fracture to be beneficial in selected patients. For the unexperienced surgeon, it is useful to be aware of the association between facial trauma, facial surgery, and CRP increase in order to avoid unnecessary infection diagnoses. However, the interpretation of CRP becomes more complicated if dexamethasone is used, as shown here.
One drawback of this study was that a considerable portion of the patients was excluded due to missing CRP variables. Preoperative CRP measurements were not included in the primary study protocol, and the variables were therefore collected retrospectively. On the other hand, the findings are undeniable and consistent in all fracture groups, and confounding factors, such as multiple fractures and infections, were not included. It should be noted that also other trauma-related factors, such as multiple injuries or massive soft tissue injuries, may affect CRP changes.
The clinical relevance of CRP and its function as an inflammation mediator are somewhat unclear. CRP has several functions in the periphery. In damaged tissues, it is an essential protein that activates the complement cascade on the surface of necrotic cells [21] . It also accelerates pro-migratory functions in wounds, supports the activity of monocytes [22] , and promotes angiogenesis [23] . Recent studies have revealed the biological role of CRP to be more complex than previously thought. Future research should elucidate the clinical effects of pharmacological systemic CRP. However, CRP measurements are not 
